Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SID142 for efficacy and safety in peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• SID142

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Peripheral Arterial Disease | Phase 3 | Status: COMPLETED